Iranian Journal of Pathology

Association of Histologic Growth Patterns and Some Histopathologic Features in Clear Cell Renal Cell Carcinoma with Patient’s Survival after Nephrectomy: A Cross-Sectional Study

Document Type : Original Research

Authors

Mehdi Farzadnia 1
Naser Tayyebi Meibodi 2
Ahmad Jafari Joshaghan 3
Mahnaz Baradaran 4
Motahare Ebrahimnejad 5
Saeid Dehghan Nezhad 5
Farideh Ranjbar 3

1 Cancer Molecular Pathology Research Center٫ Mashhad University of Medical Sciences٫ Mashhad٫ Iran

2 Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

3 Department of pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

4 Department of Pathology, School of Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

5 Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

https://doi.org/10.30699/ijp.2025.2033228.3319
Abstract
Background & Objective: Clear cell renal cell carcinoma (CCRCC) is the most common type of renal cancer. Limited studies have been conducted about factors affecting the survival of patients with CCRCC. In this study, we aimed to evaluate the association between histologic growth patterns (HGPs) and some pathologic features and survival in CCRCC.
Methods: This cross-sectional study evaluated the association between HGPs and other pathologic features and the survival of 145 patients with CCRCC after nephrectomy in Emam-Reza Hospital (Mashhad, Iran) from 2012 to 2022. Two expert pathologists assessed HGPs and other pathologic features, like cytopathologic changes. All analyses were performed using IBM SPSS version 26 software. A P value less than 0.05 was considered statistically significant.
Results: In the current study, we assessed the association of the 6 most prevalent growth patterns with the patient’s survival. Some clinicopathologic features like tumor stage and grade, tumor size, and necrosis are negatively linked with survival. Two important cytologic features, including sarcomatoid and rhabdoid, were also associated with survival time in patients with CCRCC (P values < 0.05). Regardless of the nuclear grade of the tumor, some patterns like solid sheet, papillary, and thick trabecular were associated with lower survival.
Conclusion: Some HGPs are significantly associated with the patient’s survival in CCRCC. A greater variety of patterns within each specimen has been associated with a reduced survival rate. The impact of HGPs on patient survival may be as significant as the nuclear grade.

Keywords

Carcinoma
Clear Cell Renal Cell Carcinoma
Histologic Growth Patterns
Survival
Nephrectomy

Subjects

  1. Muglia VF, Prando A. Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol Bras. 2015;48(3):166-74. [DOI:10.1590/0100-3984.2013.1927] [PMID] [PMCID]
  2. Low G, Huang G, Fu W, Moloo Z, Girgis S. Review of renal cell carcinoma and its common subtypes in radiology. World J Radiol. 2016;8(5):484. [DOI:10.4329/wjr.v8.i5.484] [PMID] [PMCID]
  3. Warren AY, Harrison D. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies. World J Urol. 2018;36:1913-26. [DOI:10.1007/s00345-018-2447-8] [PMID] [PMCID]
  4. Fukatsu A, Tsuzuki T, Sassa N, Nishikimi T, Kimura T, Majima T, et al. Growth pattern, an important pathologic prognostic parameter for clear cell renal cell carcinoma. Am J Clin Pathol. 2013;140(4):500-5. [DOI:10.1309/AJCPIMPE6ZFT8AME] [PMID]
  5. Zhang L, Yin W, Yao L, Li X, Fang D, Ren D, et al. Growth pattern of clear cell renal cell carcinoma in patients with delayed surgical intervention: fast growth rate correlates with high grade and may result in poor prognosis. Biomed Res Int. 2015;2015(1):598134. [DOI:10.1155/2015/598134] [PMID] [PMCID]
  6. Cai Q, Christie A, Rajaram S, Zhou Q, Araj E, Chintalapati S, et al. Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type. EBioMedicine. 2020;51. [DOI:10.1016/j.ebiom.2019.10.052] [PMID] [PMCID]
  7. Li Y, Lih T-SM, Dhanasekaran SM, Mannan R, Chen L, Cieslik M, et al. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer Cell. 2023;41(1): 139-63. e17. [doi: 10.1016/j.ccell.2022.12.001] [PMID] [PMCID]
  8. Kapur P, Christie A, Rajaram S, Brugarolas J. What morphology can teach us about renal cell carcinoma clonal evolution. Kidney cancer J: official journal of the Kidney Cancer Association. 2020;18(3):68. [DOI:10.52733/KCJ18n3-a1] [PMID] [PMCID]
  9. Haddad AQ, Margulis V. Tumour and patient factors in renal cell carcinoma-towards personalized therapy. Nat Rev Urol. 2015;12(5):253-62. [DOI:10.1038/nrurol.2015.71] [PMID]
  10. Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022;39(3):2022. [PMID]
  11. Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3(1):1-19. [DOI:10.1038/nrdp.2017.9] [PMID] [PMCID]
  12. Chowdhury N, Drake CG. Kidney cancer: an overview of current therapeutic approaches. J Clin Urol. 2020;47(4):419-31. [DOI:10.1016/j.ucl.2020.07.009] [PMID]
  13. Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(5):706-20. [DOI:10.1093/annonc/mdz056] [PMID]
  14. Sirohi D, Chipman J, Barry M, Albertson D, Mahlow J, Liu T, et al. Histologic growth patterns in clear cell renal cell carcinoma stratify patients into survival risk groups. Clin Genitourin Cancer. 2022;20(3):e233-e43. [DOI:10.1016/j.clgc.2022.01.005] [PMID]
  15. Verbiest A, Couchy G, Job S, Caruana L, Lerut E, Oyen R, et al. Molecular subtypes of clear-cell renal cell carcinoma are prognostic for outcome after complete metastasectomy. Eur Urol. 2018;74(4):474-80. [DOI:10.1016/j.eururo.2018.01.042] [PMID]
  16. Cai Q, Christie A, Zhou Q, Araj E, Cadeddu JA, Margulis V, et al. The role of architectural patterns and cytologic features in the prognosis of clear cell renal cell carcinoma. Am Soc Clin Oncol. 2019;51. [DOI:10.1200/JCO.2019.37.7_suppl.632]
  17. Taneja K, Cheng L, Al-Obaidy K, Kao C-S, Barletta J, Howitt BE, et al. Clear cell renal cell carcinoma with a poorly-differentiated component: a novel variant causing potential diagnostic difficulty. Case Rep. 2019; 64.
  18. Askeland EJ, Chehval VA, Askeland RW, Fosso PG, Sangale Z, Xu N, et al. Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resection. Cancer Biomark. 2015; 15(6):861-7. [DOI:10.3233/CBM-150530] [PMID]
  19. Weber T, Meinhardt M, Zastrow S, Wienke A, Fuessel S, Wirth MP. Immunohistochemical analysis of prognostic protein markers for primary localized clear cell renal cell carcinoma. Cancer Invest. 2013; 31(1):51-9. [DOI:10.3109/07357907.2012.749267] [PMID]
  20. Mukhopadhyay SG, Mukherjee K, Manna AK. Renal tumours in adults with correlation between Fuhrman grading and proliferative marker. Iran J Pathol. 2015;10(4):281. [PMID] [PMCID]
  21. Delahunt B, McKenney JK, Lohse CM, Leibovich BC, Thompson RH, Boorjian SA, Cheville JC. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis. Am J Surg Pathol. 2013;37(3):311-22. [DOI:10.1097/PAS.0b013e318270f71c] [PMID]
  22. Khor L-Y, Dhakal HP, Jia X, Reynolds JP, McKenney JK, Rini BI, et al. Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: a study of 842 consecutive cases from a single institution. Am J Surg Pathol. 2016;40(9):1224-31. [DOI:10.1097/PAS.0000000000000690] [PMID]
  23. Ohe C, Yoshida T, Amin MB, Atsumi N, Ikeda J, Saiga K, et al. Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: Correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomes. Modern Pathol. 2022;35(6):816-24. [DOI:10.1038/s41379-021-00982-9] [PMID]
  24. Wahal SP, Mardi K. Multilocular cystic renal cell carcinoma: a rare entity with review of literature. J Lab Physicians. 2014;6(01):050-2. [DOI:10.4103/0974-2727.129093] [PMID] [PMCID]
  25. Kondo T, Sassa N, Yamada H, Takagi T, Iizuka J, Kobayashi H, et al. Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study. Pathology. 2021;53(6):720-7. [DOI:10.1016/j.pathol.2021.01.014] [PMID]
  26. Swami U, Nussenzveig RH, Haaland B, Agarwal N. Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement. Ann Transl Med. 2019;7(Suppl 1). [DOI:10.21037/atm.2019.01.50] [PMID] [PMCID]
  27. Geynisman DM, Maranchie JK, Ball MW, Bratslavsky G, Singer EA, editors. A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer. Urol Oncol. 2021;39(9):548-560.[PMCID] [DOI:10.1016/j.urolonc.2021.04.038] [PMID]
  28. Nguyen DP, Vertosick EA, Corradi RB, Vilaseca A, Benfante NE, Touijer KA, et al., editors. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy. Urol Oncol. 2016;34(6):259. [DOI:10.1016/j.urolonc.2016.01.005] [PMID] [PMCID]
  29. ANDREIANA BC, STEPAN AE, MĂRGĂRITESCU C, AL KHATIB A-M, FLORESCU MM, CIUREA RN, SIMIONESCU CE. Histopathological prognostic factors in clear cell renal cell carcinoma. Curr Health Sci J. 2018;44(3):201. [PMID] [PMCID] [DOI: 10.12865/CHSJ.44.03.01]
  30. Verine J, Colin D, Nheb M, Prapotnich D, Ploussard G, Cathelineau X, et al. Architectural patterns are a relevant morphologic grading system for clear cell renal cell carcinoma prognosis assessment: comparisons with WHO/ISUP grade and integrated staging systems. Am J Surg Pathol. 2018;42(4):423-41. [DOI:10.1097/PAS.0000000000001025] [PMID]
  31. Yang C, Shuch B, Kluger H, Humphrey PA, Adeniran AJ. High WHO/ISUP grade and unfavorable architecture, rather than typing of papillary renal cell carcinoma, may be associated with worse prognosis. Am J Surg Pathol. 2020;44(5):582-93. [DOI:10.1097/PAS.0000000000001455] [PMID]
Iranian Journal of Pathology
Volume 20, Issue 2
Spring 2025
Pages 198-206

  • Receive Date 29 July 2024
  • Revise Date 01 February 2025
  • Accept Date 05 February 2025

Home

Guide for Authors

Submit Manuscript

Contact Us